MS-Forschungsprojekte 2016

• Prof. Dr. Thorsten Buch
  Director Institute of Laboratory Animal Science, University of Zurich
  Dissecting the role of pattern recognition in initiation of anti-myelin autoimmune responses



• Prof. Dr. Pasquale Calabrese
  Faculty of Psychology and Transfacultary Research Platform Psychology and Psychiatry University of Basel
  The relationship between disability, physical activity and affective disturbances in MS




• Dr. Andrea Chicca
  Institute of Biochemistry and Molecular Medicine (IBMM), University of Bern
  Potent inhibition of endocannabinoid re-uptake as a novel pharmacological strategy with potential translational application to control multiple sclerosis disease progression




• Dr. Giulio Disanto
  Neurocenter of Southern Switzerland, Ospedale Regionale sede Civico Lugano
  Prediagnostic presentations of multiple sclerosis in primary care: a case-control study




• Prof Renaud Du Pasquier, M.D
  CHUV, Service de neurologie, Laboratory of neuro-immunology, Center of research in neurosciences, Department of clinical neurosciences Lausanne
  Impact of fingolimod treatment on T cell migration to the central nervous system: a four-year observational study




• Dr. Gaby Enzmann
  Uni Bern, TKI
  Resolution of neuroinflammation as treatment for Multiple Sclerosis




• PD Dr. med. Claudio Gobbi
  Ospedale Regionale di Lugano - Civico e Italiano Civico
  Effects of repetitive transcranial magnetic stimulation and cognitive rehabilitation on cognitive functions in patients with multiple sclerosis: an explorative study with structural and functional MRI




• Prof. Stéphanie Hugues
  University of Geneva
  MHCII-mediated antigen presentation by lymphatic endothelial cells in EAE




• Prof. Dr. Andrea Huwiler
  Inst. of Pharmacology, Uni Bern, Inselspital,INO‐F, 3010 Bern
  Pharmacological characterization of a novel oxazolo-oxazole derivative of fingolimod, ST-1505 in vitro and its therapeutic efficacy in an experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice and sphingosine kinase 2 deficient mice.




• Prof. Patrice Lalive d'Epinay
  Department of Clinical Neurosciences, Division of Neurology,University Hospital of Geneva
  Functional significance of c-Met expression on effector CD8+ T lymphocytes in autoimmune CNS demyelination (extension year #2)




• Prof. Dr. Jan Lünemann
  Institute of Experimental Immunology, Uni Zurich
  Therapeutic eddicacy of low molecular weight polysialic acid in experimental autoimmune encephalomyelitis




• Dr. Matthias Mehling
  Institute of Experimental Immunology, Uni Zurich
  Chemotaxis of B cells in MS




• Dr. Maria Meira
  University Hospital Basel, Department of Biomedicine, Clinical Neuroimmunology lab
  Extracellular RNA (exRNA) signature as an indicator for natalizumab treatment response and PML risk assessment




• Dr. med. Athina Papadopoulou
  University Hospital Basel
  OCT as marker of cognitive impairment in MS




• Prof. Dr. med. Caroline Pot Kreis
  SNSF assistant Professor, Service de Neurologie, CHUV Lausanne 
  Endothelium as a source of oxysterols that fine-tune lymphocyte migration during Multiple Sclerosis




• Prof. Dr. Walter Reith
  Department of Pathology and Immunology, Facuty of Medicine, University of Geneva
  A novel T-cell co-inhibitory pathway conferring protection against CNS autoimmunity




• Dr. Georgia Salanti
  Institute of Social and Preventive Medicine, University of Bern
  Comparative effectiveness and safety of disease-modifying drugs in early treatment of multiple sclerosis




• Prof. Dr. Nicole Schaeren-Wiemers
  Neurobiology Lab, Department of Biomedicine, University Hospital Basel
  A novel animal model to study chronic grey matter changes in the brain




• Dr. Bettina Schreiner
  University of Zurich, Institute of Experimental Immunology
  In depth characterization of astroglial phenotypes in autoimmune CNS inflammation




• Dr Viktoria Szabolcsi
  University of Fribourg
  Investigation of the role of parvalbumin in myelination, de- and remyelination in the CNS




• Dr. Silvia Tietz
  Theodor Kocher Institut Bern
  The role of the mitogen-activated protein kinase-activated protein kinases (ML) 2 and MK3 in the pathogenesis of experimental autoimmune encepaomyelitis




• Dr. Tim Vanbellingen
  Zentrum für Neurologie und Neurorehabilitation, Luzerner Kantonsspital
  A new app for at-home dexterity training in Multiple Sclerosis: a randomized controlled study




• Dr. Rajeev Verma
  University Institute of Diagnostic and Interventional  Neuroradiology, Inselspital Bern in cooperation with SCAN (Support Center of Advanced  Neuroimaging)
  Do behavioral changes, beside depression and fatigue, correlate with cortical pathologies in patients with Multiple Sclerosis?




• Dr. Franca Wagner
  Inselspital Bern
  Automatic segmentations of MS lesions, brain volumetry and morphometry: Proposal of a diagnostic tool for disease monitoring




• Andrea Weise, MSc in OT (Karolinska Institute Stockholm, 2007)
  Kliniken Valens, Rehazentrum Valens
  Development and feasibility study of a three-week inpatient fatigue management education (IFME) protocol for persons with MS-related fatigue